BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

REMPEX PHARMACEUTICALS, INC. — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Termination Amendment (No Activity)

REMPEX PHARMACEUTICALS, INC.

via FABIANI & COMPANY

4th Quarter (Oct 1 - Dec 31) · 2012Posted Jan 22, 2013Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: REMPEX PHARMACEUTICALS, INC.
Description: A pharmaceutical company focused on antibacterial drug discovery and development
Location: California · United States of America

Registrant

Firm: FABIANI & COMPANY
Description: Global trade
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.